Intrinsic value of Clorox - CLX

Previous Close

$138.91

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$138.91

 
Intrinsic value premium content
 
Up/down potential premium content
 
Rating premium content
 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of CLX stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 17.9

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  1.87
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
  4.87
  4.89
  4.90
  4.91
  4.92
  4.92
  4.93
  4.94
  4.95
  4.95
  4.96
  4.96
  4.96
  4.97
  4.97
  4.97
  4.98
Revenue, $m
  5,761
  6,020
  6,294
  6,583
  6,889
  7,210
  7,550
  7,907
  8,283
  8,680
  9,097
  9,536
  9,998
  10,484
  10,994
  11,532
  12,096
  12,690
  13,314
  13,970
  14,659
  15,383
  16,143
  16,943
  17,782
  18,664
  19,591
  20,564
  21,586
  22,660
  23,787
Variable operating expenses, $m
 
  2,324
  2,425
  2,531
  2,642
  2,760
  2,885
  3,015
  3,153
  3,298
  3,451
  3,492
  3,661
  3,839
  4,026
  4,223
  4,430
  4,647
  4,876
  5,116
  5,368
  5,633
  5,912
  6,205
  6,512
  6,835
  7,175
  7,531
  7,905
  8,299
  8,711
Fixed operating expenses, $m
 
  2,679
  2,746
  2,815
  2,885
  2,958
  3,031
  3,107
  3,185
  3,265
  3,346
  3,430
  3,516
  3,603
  3,694
  3,786
  3,880
  3,978
  4,077
  4,179
  4,283
  4,390
  4,500
  4,613
  4,728
  4,846
  4,967
  5,092
  5,219
  5,349
  5,483
Total operating expenses, $m
  4,778
  5,003
  5,171
  5,346
  5,527
  5,718
  5,916
  6,122
  6,338
  6,563
  6,797
  6,922
  7,177
  7,442
  7,720
  8,009
  8,310
  8,625
  8,953
  9,295
  9,651
  10,023
  10,412
  10,818
  11,240
  11,681
  12,142
  12,623
  13,124
  13,648
  14,194
Operating income, $m
  983
  1,016
  1,123
  1,238
  1,361
  1,493
  1,634
  1,784
  1,945
  2,117
  2,300
  2,614
  2,821
  3,041
  3,275
  3,523
  3,786
  4,065
  4,361
  4,675
  5,007
  5,359
  5,731
  6,125
  6,542
  6,983
  7,449
  7,941
  8,462
  9,012
  9,593
EBITDA, $m
  1,148
  1,236
  1,348
  1,467
  1,595
  1,732
  1,879
  2,036
  2,203
  2,381
  2,571
  2,773
  2,987
  3,215
  3,458
  3,715
  3,987
  4,276
  4,583
  4,907
  5,251
  5,615
  6,000
  6,407
  6,838
  7,293
  7,775
  8,284
  8,821
  9,389
  9,989
Interest expense (income), $m
  79
  67
  69
  75
  81
  88
  95
  103
  111
  120
  128
  138
  148
  158
  169
  180
  193
  205
  219
  233
  247
  263
  279
  296
  314
  333
  353
  374
  395
  418
  443
Earnings before tax, $m
  983
  950
  1,054
  1,163
  1,279
  1,404
  1,538
  1,681
  1,834
  1,997
  2,171
  2,476
  2,673
  2,883
  3,106
  3,342
  3,593
  3,860
  4,142
  4,442
  4,760
  5,096
  5,452
  5,829
  6,228
  6,650
  7,096
  7,568
  8,066
  8,593
  9,150
Tax expense, $m
  335
  256
  285
  314
  345
  379
  415
  454
  495
  539
  586
  669
  722
  778
  838
  902
  970
  1,042
  1,118
  1,199
  1,285
  1,376
  1,472
  1,574
  1,682
  1,795
  1,916
  2,043
  2,178
  2,320
  2,471
Net income, $m
  648
  693
  770
  849
  934
  1,025
  1,123
  1,227
  1,339
  1,458
  1,585
  1,808
  1,951
  2,104
  2,267
  2,440
  2,623
  2,818
  3,024
  3,243
  3,475
  3,720
  3,980
  4,255
  4,546
  4,854
  5,180
  5,524
  5,889
  6,273
  6,680

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  401
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  4,510
  4,294
  4,489
  4,696
  4,913
  5,143
  5,385
  5,640
  5,908
  6,191
  6,489
  6,802
  7,131
  7,478
  7,842
  8,225
  8,628
  9,051
  9,496
  9,964
  10,455
  10,972
  11,514
  12,085
  12,683
  13,313
  13,973
  14,668
  15,397
  16,162
  16,967
Adjusted assets (=assets-cash), $m
  4,109
  4,294
  4,489
  4,696
  4,913
  5,143
  5,385
  5,640
  5,908
  6,191
  6,489
  6,802
  7,131
  7,478
  7,842
  8,225
  8,628
  9,051
  9,496
  9,964
  10,455
  10,972
  11,514
  12,085
  12,683
  13,313
  13,973
  14,668
  15,397
  16,162
  16,967
Revenue / Adjusted assets
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
  1.402
Average production assets, $m
  1,572
  1,644
  1,718
  1,797
  1,881
  1,968
  2,061
  2,159
  2,261
  2,370
  2,483
  2,603
  2,729
  2,862
  3,001
  3,148
  3,302
  3,464
  3,635
  3,814
  4,002
  4,199
  4,407
  4,625
  4,855
  5,095
  5,348
  5,614
  5,893
  6,186
  6,494
Working capital, $m
  -73
  54
  57
  59
  62
  65
  68
  71
  75
  78
  82
  86
  90
  94
  99
  104
  109
  114
  120
  126
  132
  138
  145
  152
  160
  168
  176
  185
  194
  204
  214
Total debt, $m
  2,312
  1,964
  2,139
  2,325
  2,521
  2,728
  2,945
  3,175
  3,416
  3,671
  3,939
  4,221
  4,517
  4,829
  5,157
  5,502
  5,864
  6,245
  6,646
  7,067
  7,509
  7,974
  8,462
  8,975
  9,514
  10,080
  10,675
  11,300
  11,956
  12,645
  13,369
Total liabilities, $m
  4,213
  3,865
  4,040
  4,226
  4,422
  4,629
  4,846
  5,076
  5,317
  5,572
  5,840
  6,122
  6,418
  6,730
  7,058
  7,403
  7,765
  8,146
  8,547
  8,968
  9,410
  9,875
  10,363
  10,876
  11,415
  11,981
  12,576
  13,201
  13,857
  14,546
  15,270
Total equity, $m
  297
  429
  449
  470
  491
  514
  538
  564
  591
  619
  649
  680
  713
  748
  784
  823
  863
  905
  950
  996
  1,046
  1,097
  1,151
  1,208
  1,268
  1,331
  1,397
  1,467
  1,540
  1,616
  1,697
Total liabilities and equity, $m
  4,510
  4,294
  4,489
  4,696
  4,913
  5,143
  5,384
  5,640
  5,908
  6,191
  6,489
  6,802
  7,131
  7,478
  7,842
  8,226
  8,628
  9,051
  9,497
  9,964
  10,456
  10,972
  11,514
  12,084
  12,683
  13,312
  13,973
  14,668
  15,397
  16,162
  16,967
Debt-to-equity ratio
  7.785
  4.570
  4.770
  4.950
  5.130
  5.300
  5.470
  5.630
  5.780
  5.930
  6.070
  6.210
  6.330
  6.460
  6.580
  6.690
  6.800
  6.900
  7.000
  7.090
  7.180
  7.270
  7.350
  7.430
  7.500
  7.570
  7.640
  7.700
  7.770
  7.820
  7.880
Adjusted equity ratio
  0.072
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  648
  693
  770
  849
  934
  1,025
  1,123
  1,227
  1,339
  1,458
  1,585
  1,808
  1,951
  2,104
  2,267
  2,440
  2,623
  2,818
  3,024
  3,243
  3,475
  3,720
  3,980
  4,255
  4,546
  4,854
  5,180
  5,524
  5,889
  6,273
  6,680
Depreciation, amort., depletion, $m
  165
  220
  224
  229
  234
  240
  245
  251
  258
  264
  271
  159
  166
  175
  183
  192
  201
  211
  222
  233
  244
  256
  269
  282
  296
  311
  326
  342
  359
  377
  396
Funds from operations, $m
  682
  913
  994
  1,078
  1,168
  1,265
  1,368
  1,479
  1,597
  1,722
  1,856
  1,966
  2,118
  2,279
  2,450
  2,632
  2,824
  3,029
  3,246
  3,475
  3,719
  3,976
  4,249
  4,537
  4,842
  5,165
  5,506
  5,867
  6,248
  6,650
  7,076
Change in working capital, $m
  -96
  2
  2
  3
  3
  3
  3
  3
  3
  4
  4
  4
  4
  4
  5
  5
  5
  5
  6
  6
  6
  7
  7
  7
  8
  8
  8
  9
  9
  10
  10
Cash from operations, $m
  778
  980
  992
  1,076
  1,166
  1,262
  1,365
  1,475
  1,593
  1,719
  1,852
  1,962
  2,114
  2,275
  2,445
  2,627
  2,819
  3,024
  3,240
  3,469
  3,712
  3,970
  4,242
  4,530
  4,835
  5,157
  5,498
  5,858
  6,239
  6,641
  7,066
Maintenance CAPEX, $m
  0
  -96
  -100
  -105
  -110
  -115
  -120
  -126
  -132
  -138
  -144
  -151
  -159
  -166
  -175
  -183
  -192
  -201
  -211
  -222
  -233
  -244
  -256
  -269
  -282
  -296
  -311
  -326
  -342
  -359
  -377
New CAPEX, $m
  -172
  -72
  -75
  -79
  -83
  -88
  -93
  -98
  -103
  -108
  -114
  -120
  -126
  -133
  -139
  -147
  -154
  -162
  -170
  -179
  -188
  -198
  -208
  -218
  -229
  -241
  -253
  -266
  -279
  -293
  -308
Cash from investing activities, $m
  -430
  -168
  -175
  -184
  -193
  -203
  -213
  -224
  -235
  -246
  -258
  -271
  -285
  -299
  -314
  -330
  -346
  -363
  -381
  -401
  -421
  -442
  -464
  -487
  -511
  -537
  -564
  -592
  -621
  -652
  -685
Free cash flow, $m
  348
  812
  817
  892
  973
  1,059
  1,153
  1,252
  1,359
  1,473
  1,594
  1,691
  1,829
  1,976
  2,131
  2,297
  2,473
  2,660
  2,858
  3,069
  3,292
  3,528
  3,778
  4,043
  4,323
  4,620
  4,934
  5,266
  5,617
  5,988
  6,380
Issuance/(repayment) of debt, $m
  126
  53
  176
  186
  196
  207
  218
  229
  242
  254
  268
  282
  296
  312
  328
  345
  363
  381
  401
  421
  442
  465
  488
  513
  539
  566
  595
  625
  656
  689
  724
Issuance/(repurchase) of shares, $m
  -44
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  82
  53
  176
  186
  196
  207
  218
  229
  242
  254
  268
  282
  296
  312
  328
  345
  363
  381
  401
  421
  442
  465
  488
  513
  539
  566
  595
  625
  656
  689
  724
Total cash flow (excl. dividends), $m
  417
  865
  993
  1,077
  1,169
  1,266
  1,370
  1,482
  1,600
  1,727
  1,862
  1,973
  2,125
  2,287
  2,459
  2,642
  2,836
  3,041
  3,259
  3,490
  3,734
  3,993
  4,266
  4,556
  4,862
  5,186
  5,529
  5,891
  6,273
  6,678
  7,104
Retained Cash Flow (-), $m
  -179
  -132
  -20
  -21
  -22
  -23
  -24
  -25
  -27
  -28
  -30
  -31
  -33
  -35
  -36
  -38
  -40
  -42
  -45
  -47
  -49
  -52
  -54
  -57
  -60
  -63
  -66
  -69
  -73
  -77
  -80
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  733
  973
  1,057
  1,147
  1,243
  1,346
  1,456
  1,574
  1,699
  1,832
  1,942
  2,092
  2,253
  2,423
  2,604
  2,796
  2,999
  3,214
  3,443
  3,685
  3,941
  4,212
  4,499
  4,803
  5,124
  5,463
  5,822
  6,201
  6,601
  7,024
Discount rate, %
 
  7.80
  8.19
  8.60
  9.03
  9.48
  9.95
  10.45
  10.98
  11.52
  12.10
  12.71
  13.34
  14.01
  14.71
  15.44
  16.22
  17.03
  17.88
  18.77
  19.71
  20.70
  21.73
  22.82
  23.96
  25.16
  26.41
  27.73
  29.12
  30.58
  32.11
PV of cash for distribution, $m
 
  680
  831
  825
  812
  790
  762
  726
  684
  636
  585
  521
  466
  410
  355
  302
  252
  207
  166
  131
  101
  76
  56
  40
  28
  19
  12
  8
  5
  3
  2
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox and Clorox 2 stain fighter and color booster brand names; home care products under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brand names; naturally derived products under the Green Works brand name; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brand names. It also provides charcoal products under the Kingsford and Match Light brand names; cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; digestive health products under the Renew Life brand name; and bags, wraps, and containers under the Glad brand name. In addition, the company offers dressings and sauces under the Hidden Valley, KC Masterpiece, and Soy Vay brand names; water-filtration systems and filters under the Brita brand name; and natural personal care products under the Burt’s Bees brand name. Further, it markets its products under the PinoLuz, Ayudin, Limpido, Clorinda, Poett, Mistolin, Lestoil, Bon Bril, Agua Jane, and Chux brand names. The company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors, and medical supply distributors to mass merchandisers, warehouse clubs, and grocery stores and wholesalers, as well as dollar, military, and other retail stores. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.

FINANCIAL RATIOS  of  Clorox (CLX)

Valuation Ratios
P/E Ratio 27.7
Price to Sales 3.1
Price to Book 60.5
Price to Tangible Book
Price to Cash Flow 23.1
Price to Free Cash Flow 29.7
Growth Rates
Sales Growth Rate 1.9%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 37.6%
Cap. Spend. - 3 Yr. Gr. Rate -2.4%
Financial Strength
Quick Ratio 1
Current Ratio 0
LT Debt to Equity 602.4%
Total Debt to Equity 778.5%
Interest Coverage 13
Management Effectiveness
Return On Assets 16.1%
Ret/ On Assets - 3 Yr. Avg. 15.2%
Return On Total Capital 26.4%
Ret/ On T. Cap. - 3 Yr. Avg. 24.3%
Return On Equity 312.3%
Return On Equity - 3 Yr. Avg. 370.3%
Asset Turnover 1.3
Profitability Ratios
Gross Margin 45.1%
Gross Margin - 3 Yr. Avg. 43.8%
EBITDA Margin 21.3%
EBITDA Margin - 3 Yr. Avg. 21%
Operating Margin 17.1%
Oper. Margin - 3 Yr. Avg. 16.4%
Pre-Tax Margin 17.1%
Pre-Tax Margin - 3 Yr. Avg. 16.5%
Net Profit Margin 11.2%
Net Profit Margin - 3 Yr. Avg. 10.5%
Effective Tax Rate 34.1%
Eff/ Tax Rate - 3 Yr. Avg. 34.3%
Payout Ratio 61.4%

CLX stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CLX stock intrinsic value calculation we used $5761 million for the last fiscal year's total revenue generated by Clorox. The default revenue input number comes from 2016 income statement of Clorox. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CLX stock valuation model: a) initial revenue growth rate of 4.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.8%, whose default value for CLX is calculated based on our internal credit rating of Clorox, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Clorox.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CLX stock the variable cost ratio is equal to 38.7%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $2614 million in the base year in the intrinsic value calculation for CLX stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Clorox.

Corporate tax rate of 27% is the nominal tax rate for Clorox. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CLX stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CLX are equal to 27.3%.

Life of production assets of 16.4 years is the average useful life of capital assets used in Clorox operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CLX is equal to 0.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $297 million for Clorox - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 128.609 million for Clorox is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Clorox at the current share price and the inputted number of shares is $17.9 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
OBCI Ocean Bio-Chem 3.94 prem.  prem.
CHD Church&Dwight 53.04 prem.  prem.
PG Procter&Gamble 89.42 prem.  prem.
WDFC WD-40 109.90 prem.  prem.
CL Colgate-Palmol 75.92 prem.  prem.

COMPANY NEWS

▶ America's Most Beloved CEOs Ranked   [Jun-23-17 02:34PM  Investopedia]
▶ The 10 Bay Area CEOs with the highest employee approval ratings   [09:58AM  American City Business Journals]
▶ These CEOs are the best in the business   [Jun-21-17 01:55PM  Yahoo Finance Video]
▶ These Greater Washington CEOs are some of the country's highest rated   [12:00AM  American City Business Journals]
▶ Heres who could lead Uber out of its scandals   [Jun-20-17 03:15PM  Yahoo Finance]
▶ Why Church & Dwights Margins Stand Out   [07:37AM  Market Realist]
▶ How Clorox Is Outperforming Peers in Top-Line Growth   [Jun-13-17 10:37AM  Market Realist]
▶ Most Asian stock markets rise after Wall Street loss   [May-31-17 11:43PM  Associated Press]
▶ 3 Dividend Stocks That Thrive in Market Crashes   [May-27-17 07:26AM  Motley Fool]
▶ ETFs with exposure to The Clorox Co. : May 23, 2017   [May-23-17 12:33PM  Capital Cube]
▶ These 3 Stocks Just Raised Their Dividends   [May-18-17 08:34AM  Motley Fool]
▶ Biggest Winner: Colgate Palmolive Cleans Up   [May-17-17 04:56PM  Barrons.com]
▶ 3 Dividend Stocks for Bright Investors   [May-16-17 08:19PM  Motley Fool]
▶ ETFs with exposure to The Clorox Co. : May 12, 2017   [May-12-17 03:49PM  Capital Cube]
▶ Clorox Increases Dividend, Stock Gains   [May-09-17 10:50AM  TheStreet.com]
▶ Clorox Hikes Dividend 5%, Shares Climb   [10:35AM  Barrons.com]
▶ How Cloroxs Valuation Compares to Its Peers   [09:05AM  Market Realist]
▶ What Analysts Recommend for Clorox Stock   [07:36AM  Market Realist]
▶ Clorox Disappoints on Margins in Fiscal 3Q17   [10:36AM  Market Realist]
▶ Whats behind Cloroxs Fiscal 3Q17 Earnings Beat?   [May-04-17 05:05PM  Market Realist]
▶ Company News for May 04, 2017   [10:08AM  Zacks]
▶ Clorox beats 3Q profit forecasts   [06:38AM  Associated Press]
▶ What Drove Colgate-Palmolives 1Q Bottom Line?   [May-01-17 04:35PM  Market Realist]
▶ What Analysts Think about Clorox Stock   [Apr-27-17 09:08AM  Market Realist]
▶ Will Clorox Outperform Its Peers with Sales Growth?   [Apr-26-17 05:05PM  Market Realist]
▶ The Clorox Co. Value Analysis (NYSE:CLX) : April 25, 2017   [Apr-25-17 04:08PM  Capital Cube]
▶ 3 Dividend Aristocrats We Refuse to Buy   [09:09AM  Motley Fool]
▶ Clorox Offers Clean Solution for Strength   [Apr-20-17 02:22PM  TheStreet.com]
▶ Colgate, Clorox & Procter: The Uninvestable?   [Apr-19-17 11:28AM  Barrons.com]
▶ Clorox Stock Trades Ex-Dividend Monday   [Apr-13-17 08:34AM  Investopedia]
▶ Neural Networks and Suspicious Edge   [Mar-28-17 09:28AM  Bloomberg]
▶ Clorox Has Clean Path to New Highs   [03:54PM  TheStreet.com]
▶ How Clorox Is Trading among Peers Now   [10:37AM  Market Realist]
▶ Why Clorox Is Pro-Investor   [07:38AM  Market Realist]
▶ 3 Stocks to Hold for the Next 50 Years   [Mar-23-17 10:42AM  at Motley Fool]
Stock chart of CLX Financial statements of CLX Annual reports of CLX
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.